ELV
Elevance Health Inc
NYSE: ELV · HEALTHCARE · HEALTHCARE PLANS
$376.42
-0.06% today
Updated 2026-04-29
Market cap
$74.87B
P/E ratio
14.60
P/S ratio
0.37x
EPS (TTM)
$23.62
Dividend yield
1.98%
52W range
$269 – $415
Volume
2.0M
Elevance Health Inc (ELV) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $57.01B | $61.39B | $62.46B | $61.64B | $58.84B | $60.80B | $61.53B | $71.12B | $73.92B | $79.24B | $84.98B | $90.04B | $92.11B | $104.21B | $121.87B | $138.64B | $156.59B | $171.34B | $176.81B | $199.13B |
| Revenue growth (YoY) | — | +7.7% | +1.7% | -1.3% | -4.5% | +3.3% | +1.2% | +15.6% | +3.9% | +7.2% | +7.2% | +6.0% | +2.3% | +13.1% | +16.9% | +13.8% | +13.0% | +9.4% | +3.2% | +12.6% |
| Cost of revenue | $42.52B | $46.44B | $48.21B | $46.99B | $44.93B | $47.65B | $48.21B | $56.24B | $56.85B | $61.12B | $66.83B | $72.24B | $71.89B | $81.79B | $88.05B | $102.64B | $116.64B | $124.33B | $127.57B | $148.22B |
| Gross profit | $14.49B | $14.96B | $14.25B | $14.65B | $13.91B | $13.16B | $13.32B | $14.89B | $17.07B | $18.12B | $18.14B | $17.80B | $20.21B | $22.43B | $33.82B | $35.99B | $39.95B | $47.01B | $49.24B | $50.90B |
| Gross margin | 25.4% | 24.4% | 22.8% | 23.8% | 23.6% | 21.6% | 21.6% | 20.9% | 23.1% | 22.9% | 21.4% | 19.8% | 21.9% | 21.5% | 27.8% | 26.0% | 25.5% | 27.4% | 27.9% | 25.6% |
| R&D | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| SG&A | $7.16B | $6.98B | $6.72B | $7.42B | $7.12B | $6.82B | $7.09B | $8.43B | $10.26B | $11.09B | $11.17B | $11.25B | $14.02B | $13.36B | $17.45B | $6.91M | $7.45B | — | — | — |
| Operating income | $5.36B | $5.95B | $4.96B | $4.94B | $4.83B | $4.48B | $4.41B | $4.69B | $5.10B | $5.36B | $5.42B | $4.99B | $5.84B | $6.73B | $7.71B | $8.95B | $8.45B | $8.74B | $8.89B | $8.11B |
| Operating margin | 9.4% | 9.7% | 7.9% | 8.0% | 8.2% | 7.4% | 7.2% | 6.6% | 6.9% | 6.8% | 6.4% | 5.5% | 6.3% | 6.5% | 6.3% | 6.5% | 5.4% | 5.1% | 5.0% | 4.1% |
| EBITDA | $5.91B | $6.28B | $4.18B | $8.40B | $5.37B | $5.03B | $5.11B | $5.35B | $5.82B | $6.19B | $6.19B | $5.59B | $6.95B | $7.86B | $8.18B | $10.03B | $10.13B | $10.49B | $10.48B | $9.66B |
| EBITDA margin | 10.4% | 10.2% | 6.7% | 13.6% | 9.1% | 8.3% | 8.3% | 7.5% | 7.9% | 7.8% | 7.3% | 6.2% | 7.5% | 7.5% | 6.7% | 7.2% | 6.5% | 6.1% | 5.9% | 4.9% |
| EBIT | $5.78B | $6.16B | $3.61B | $7.85B | $4.77B | $4.39B | $4.37B | $4.44B | $4.97B | $5.28B | $5.28B | $4.70B | $5.82B | $6.73B | $7.02B | $8.72B | $8.45B | $8.74B | $9.09B | $8.11B |
| Interest expense | $403.50M | $447.90M | $469.80M | $447.40M | $418.90M | $430.30M | $511.80M | $602.70M | $600.70M | $653.00M | $723.00M | $739.00M | $753.00M | $746.00M | $784.00M | $798.00M | $851.00M | $1.03B | $1.19B | $1.40B |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $3.09B | $3.35B | $2.49B | $4.75B | $2.89B | $2.65B | $2.66B | $2.65B | $2.57B | $2.56B | $2.47B | $3.84B | $3.75B | $4.81B | $4.57B | $6.10B | $5.89B | $5.99B | $5.98B | $5.66B |
| Net income growth (YoY) | — | +8.1% | -25.5% | +90.5% | -39.2% | -8.3% | +0.3% | -0.0% | -3.2% | -0.4% | -3.5% | +55.6% | -2.4% | +28.2% | -4.9% | +33.5% | -3.4% | +1.6% | -0.1% | -5.3% |
| Profit margin | 5.4% | 5.4% | 4.0% | 7.7% | 4.9% | 4.4% | 4.3% | 3.7% | 3.5% | 3.2% | 2.9% | 4.3% | 4.1% | 4.6% | 3.8% | 4.4% | 3.8% | 3.5% | 3.4% | 2.8% |